Modulation of the delayed rectifier K+ current in neurons by an angiotensin II type 2 receptor fragment

• Published in: The American journal of physiology Vol. 268; no. 1 Pt 1; p. C278
• Main Authors: Kang, J, Richards, E M, Posner, P, Sumners, C
• Format: Journal Article
• Language: English
• Published: United States 01.01.1995
• Subjects: Amino Acid Sequence; Angiotensin II - pharmacology; Animals; Cells, Cultured; Electric Conductivity; Ethers, Cyclic - pharmacology; Molecular Sequence Data; Neurons - physiology; Okadaic Acid; Peptide Fragments - pharmacology; Pertussis Toxin; Potassium - physiology; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin - genetics; Time Factors; Virulence Factors, Bordetella - pharmacology
• ISSN: 0002-9513
• DOI: 10.1152/ajpcell.1995.268.1.c278

Angiotensin II (ANG II) stimulates the delayed rectifier K+ current (IK) in neurons cultured from rat hypothalamus and brain stem via AT2 receptors, and this effect involves activation of a Gi protein and protein phosphatase 2A (PP2A). However, there was no evidence that the AT2 receptor involved in this response was the same as the recently cloned AT2 receptor. In the present study, intracellular injection of a 22-amino acid peptide (PEP-22) corresponding to the putative third intracellular loop of the cloned AT2 receptor elicited an increase in IK in cultured neurons that was similar to the effect produced by ANG II. Furthermore, this effect of PEP-22 was abolished by pertussis toxin (200 ng/ml, 24 h) pretreatment and also by superfusion of the PP2A inhibitor okadaic acid (10 nM), suggesting the involvement of Gi protein and PP2A, respectively. Intracellular injection of a random peptide or normal pipette solution did not affect neuronal IK. This is direct evidence to link the cloned AT2 receptor to a defined response elicited by ANG II.